Thursday, April 16, 2020

Coronavirus (COVID-19) Update: FDA Continues User-Fee Related Reviews Through COVID-19 

The following is attributed to FDA Commissioner Stephen M. Hahn, M.D.
The U.S. Food and Drug Administration’s User Fee programs help us fulfill our mission to protect public health while also helping to accelerate innovation in industry and bring new treatment options to the American public. Throughout this public health emergency, we’ve continued to execute our review activities while responding to the public health needs of the current COVID-19 pandemic.

We continue to perform our user fee review activities and our application review teams across the agency remain focused on their work as we do everything possible to maintain continuity of operations in a very dynamic situation. Part of these actions include looking at ways to....

No comments: